Your browser doesn't support javascript.
loading
PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma.
Mittlmeier, L M; Unterrainer, M; Todica, A; Cyran, C C; Rodler, S; Bartenstein, P; Stief, C G; Ilhan, H; Staehler, M.
Afiliação
  • Mittlmeier LM; Department of Urology, University Hospital, LMU Munich, Munich, Germany.
  • Unterrainer M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Todica A; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Cyran CC; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
  • Rodler S; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Bartenstein P; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
  • Stief CG; Department of Urology, University Hospital, LMU Munich, Munich, Germany.
  • Ilhan H; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Staehler M; Department of Urology, University Hospital, LMU Munich, Munich, Germany.
Eur J Nucl Med Mol Imaging ; 47(9): 2216-2217, 2020 08.
Article em En | MEDLINE | ID: mdl-31925458
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2020 Tipo de documento: Article